Company Quick10K Filing
Resolute Oncology
10-K 2020-12-31 Filed 2021-03-01
10-Q 2020-09-30 Filed 2020-11-05
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-01
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-02-26
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-02-26
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-02-27
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-25
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-02-26
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-06
10-K 2013-12-31 Filed 2014-02-27
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-07
10-Q 2013-03-31 Filed 2013-05-08
10-K 2012-12-31 Filed 2013-02-27
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-03-17
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
8-K 2020-11-04
8-K 2020-08-05
8-K 2020-05-13
8-K 2020-04-29
8-K 2020-02-11
8-K 2019-11-06
8-K 2019-10-01
8-K 2019-08-07
8-K 2019-05-16
8-K 2019-05-07
8-K 2019-02-07
8-K 2018-11-06
8-K 2018-08-07
8-K 2018-05-16
8-K 2018-05-08
8-K 2018-02-07

Resolute Oncology Financials

PRI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Banner Energy Services Corp. (BANM)
AVIENT CORP (AVNT)
11 Good Energy (ELVN)
COWEN INC. (COWNL)
1347 Capital Corp (TFSC)
CAI International, Inc. (CAI-PA)
Avianca Holdings S.A. (AVHOQ)
Gamco Investors (GBL) 506 0% 4.3 45% 179 147 307 0 81 103 444
BANK BRADESCO (BBDO)
BIO-RAD LABORATORIES, INC. (BIO-B)
Fortress Transportation & Infrastructure Investors LLC (FTAI-PC)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Intevac (IVAC) 107 33% -678.8 -3% 124 35 73 24 -4 -0 90
1st United Bancorp (FUBC)
CIT GROUP INC (CIT-PB)
2-Track Global (TTG)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash114154136156108186112203118147149158151165193180154161152176213195212186154177280191159225262280245238
Accounts Receivable
Inventory
PP&E96113921019499112
Assets10,17010,0089,99910,0749,95110,43410,33810,43310,00510,20010,33010,38810,59410,74310,73810,72410,78110,56310,61211,01311,20511,36911,43911,67011,94512,20712,46112,49312,49712,70812,59513,07713,31813,452
Accounts Payable
Long-Term Debt375
Liabilities8,6238,4368,5768,6878,6749,0979,0629,1258,8599,0049,1089,1359,2919,4489,4939,4859,5849,4169,4669,8409,99710,14810,21810,42310,67610,92611,04211,06611,09611,26411,13411,55511,73211,844
Stockholders' Equity1,5471,5721,4231,3871,2771,3371,2751,3081,1461,1961,1731,2071,2211,2211,2461,2691,2811,4191,4271,4011,4431,4621,5211,5861,608
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue275276276287311299305308312319327324331339345345351356354363379384394405414427443460468485487495505521
Cost of Revenue
Gross Profit
R&D
SG&A
Tax2423222226252121242320232622242328262425333030233334-6017272621233029
Net Income444141424746403943433745574245434949484559585752636716866878587799796
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1880-1629951364-123897383362-196619561183569615367901794612166119136
Cash Investing221043295-72123595-4-90-4-13-10116-273332-984817-29-34-45-1-49-72-1025-82-58
Cash Financing-2-202-2-16453-98-9-167-5-5-23-28-37-88-50-79-79-28-61-48-49-45-54-67-27-63-45-75-72-85